NEWS
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
François Santinon
McGill University - Montreal / Canada
Medical and Health Sciences / Immunology
AD Scientific Index ID: 4931939
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
François Santinon's MOST POPULAR ARTICLES
1-)
In vivo expansion of activated Foxp3+ regulatory T cells and establishment of a type 2 immune response upon IL-33 treatment protect against experimental arthritis J Biton, S Khaleghparast Athari, A Thiolat, F Santinon, D Lemeiter, ... The Journal of Immunology 197 (5), 1708-1719, 2016 552016
2-)
Melanoma plasticity: promoter of metastasis and resistance to therapyF Huang, F Santinon, RE Flores González, SV Del RincónFrontiers in oncology 11, 756001, 2021292021
3-)
Involvement of Tumor Necrosis Factor Receptor Type II in FoxP3 Stability and as a Marker of Treg Cells Specifically Expanded by Anti–Tumor Necrosis Factor …F Santinon, M Batignes, ML Mebrek, J Biton, G Clavel, R Hervé, ...Arthritis & Rheumatology 72 (4), 576-587, 2020272020
4-)
Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapyJ Krueger, F Santinon, A Kazanova, ME Issa, B Larrivee, R Kremer, ...PloS one 16 (6), e0251731, 2021132021
5-)
Direct AKT activation in tumor-infiltrating lymphocytes markedly increases interferon-γ (IFN-γ) for the regression of tumors resistant to PD-1 checkpoint blockadeF Santinon, BF Ezzahra, M Bachais, A Sarabia Pacis, CE RuddScientific Reports 12 (1), 18509, 202292022
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept